We are live on ! Find out more
Stifel Financial

Stifel Financial Portfolio holdings

AUM $109B
1-Year Est. Return 21.36%
This Fund
S&P 500
This Quarter Est. Return
+1.11%
1 Year Est. Return
+21.36%
3 Year Est. Return
+66.37%
5 Year Est. Return
+85.41%
10 Year Est. Return
+302.98%
AUM
$96B
AUM Growth
+$648M
Cap. Flow
+$1.07B
Cap. Flow %
1.12%
Top 10 Hldgs %
17.56%
Holding
3,522
New
154
Increased
1,696
Reduced
1,434
Closed
149

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$192M
2
CMI icon
Cummins
CMI
+$134M
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$83.2M
4
HSIC icon
Henry Schein
HSIC
+$78.8M
5
WMT icon
Walmart Inc
WMT
+$75.8M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Industrials 9.96%
3 Financials 9.37%
4 Healthcare 8.44%
5 Consumer Staples 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAN
3301
DELISTED
GAN Ltd
GAN
$56.2K ﹤0.01%
30,900
-10,000
-24% -$18.2K
XFOR icon
3302
X4 Pharmaceuticals
XFOR
$405M
$55.5K ﹤0.01%
2,520
-1,562
-38% -$24.9K
CXE
3303
DELISTED
MFS High Income Municipal Trust
CXE
$55.4K ﹤0.01%
15,061
NIO icon
3304
NIO
NIO
$11.9B
$54.5K ﹤0.01%
12,496
-11,232
-47% -$57.2K
OXLC
3305
Oxford Lane Capital
OXLC
$903M
$54.1K ﹤0.01%
+2,134
New +$55.9K
BENF icon
3306
Beneficient
BENF
$46.9M
$54K ﹤0.01%
9,063
+6,025
+198% +$52K
CTOS icon
3307
Custom Truck One Source
CTOS
$2.42B
$53.2K ﹤0.01%
11,070
+1,036
+10% +$4.69K
MASS icon
3308
908 Devices
MASS
$345M
$51.7K ﹤0.01%
+23,509
New +$67.3K
WOW
3309
DELISTED
WideOpenWest
WOW
$49.9K ﹤0.01%
10,069
-7
-0.1% -$36
EOD
3310
Allspring Global Dividend Opportunity Fund
EOD
$281M
$49.7K ﹤0.01%
10,000
MAPS
3311
DELISTED
WM TECHNOLOGY INC A
MAPS
$49K ﹤0.01%
35,500
+3,650
+11% +$3.92K
CCCC icon
3312
C4 Therapeutics
CCCC
$399M
$48.1K ﹤0.01%
13,361
-15,054
-53% -$74.9K
VOC icon
3313
VOC Energy
VOC
$50.8M
$47.8K ﹤0.01%
10,010
TBLA icon
3314
Taboola.com
TBLA
$1.45B
$46.5K ﹤0.01%
12,750
NUVB icon
3315
Nuvation Bio
NUVB
$2.14B
$45.4K ﹤0.01%
17,070
+1,660
+11% +$4.27K
TRVI icon
3316
Trevi Therapeutics
TRVI
$2.66B
$45.4K ﹤0.01%
11,015
-298
-3% -$954
CTSO icon
3317
Cytosorbents Corp
CTSO
$23.1M
$43.7K ﹤0.01%
48,000
+3,000
+7% +$2.94K
IKT icon
3318
Inhibikase Therapeutics
IKT
$347M
$42.7K ﹤0.01%
+13,129
New +$32.8K
ZVIA icon
3319
Zevia
ZVIA
$121M
$42.1K ﹤0.01%
+10,050
New +$20.5K
RLAY icon
3320
Relay Therapeutics
RLAY
$4.26B
$42K ﹤0.01%
+10,200
New +$55.5K
BTBT icon
3321
Bit Digital
BTBT
$492M
$41.1K ﹤0.01%
14,027
+3,320
+31% +$13.1K
MQ icon
3322
Marqeta
MQ
$1.88B
$40.7K ﹤0.01%
+2,687
New +$47.2K
BBD icon
3323
Banco Bradesco
BBD
$37.9B
$38.8K ﹤0.01%
+20,305
New +$47.6K
CCO icon
3324
Clear Channel Outdoor Holdings
CCO
$1.23B
$38.5K ﹤0.01%
28,113
ABSI icon
3325
Absci
ABSI
$1.44B
$37.4K ﹤0.01%
14,278
-4,873
-25% -$17.2K

Similar funds

Stifel Financial's Q4 2024 Portfolio in Review

As of Q4 2024, Stifel Financial held 3,522 positions worth $96B, up 0.68% from $95.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Stifel Financial's Q4 2024 filing shows 154 new, 1,696 increased, 1,434 reduced and 149 closed positions. Its largest new stake was T. Rowe Price Small-Mid Cap ETF: 296,457 shares worth $9.56M. The largest sale was Nike, an estimated $192M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

  • Stifel Financial's largest Q4 2024 buy was T. Rowe Price Small-Mid Cap ETF: 296,457 shares worth $9.56M.
  • Stifel Financial added most to Marsh in Q4 2024, an estimated $418M increase.
  • Stifel Financial's biggest Q4 2024 reduction was Nike, cutting an estimated $192M.
  • Stifel Financial fully exited BondBloxx Bloomberg One Year Target Duration US Treasury ETF in Q4 2024, selling an estimated $19.7M.
  • Stifel Financial's ten largest holdings make up 18% of its $96B portfolio in Q4 2024.
  • Stifel Financial opened 154 new positions and closed 149 in Q4 2024.
  • Stifel Financial's portfolio value rose 0.68% quarter-over-quarter to $96B.

Based on Stifel Financial's 13F filing for Q4 2024, filed 13 Feb 2025.